Q2 2025 EPS Estimates for Dolby Laboratories, Inc. (NYSE:DLB) Decreased by Zacks Research

Dolby Laboratories, Inc. (NYSE:DLB – Get Rating) – Zacks Research lowered their Q2 2025 EPS estimates for Dolby Laboratories in a research report issued on Monday, May 22nd. Zacks Research analyst V. Doshi now anticipates that the electronics maker will earn $0.79 per share for the quarter, down from their previous forecast of $0.85. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.47 per share.

Several other equities analysts also recently issued reports on DLB. TheStreet upgraded shares of Dolby Laboratories from a “c” rating to a “b” rating in a report on Friday, February 3rd. StockNews.com began coverage on Dolby Laboratories in a research report on Thursday, May 18th. They issued a “buy” rating on the stock. Rosenblatt Securities upped their price objective on Dolby Laboratories from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Friday, February 3rd. Finally, Tigress Financial restated a “buy” rating and issued a $116.00 price objective on shares of Dolby Laboratories in a research report on Friday, April 14th. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $103.00.

Dolby Laboratories Stock Down 1.0 %

DLB opened at $81.90 on Wednesday. Dolby Laboratories has a 52-week low of $61.55 and a 52-week high of $88.06. The company has a market cap of $7.82 billion, a P/E ratio of 33.16, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. The firm’s 50-day moving average price is $83.78 and its 200-day moving average price is $78.77.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 23rd. Investors of record on Tuesday, May 16th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend was Monday, May 15th. Dolby Laboratories’s dividend payout ratio is currently 43.72%.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 15,000 shares of the firm’s stock in a transaction on Monday, May 8th. The stock was sold at an average price of $83.59, for a total value of $1,253,850.00. Following the completion of the sale, the executive vice president now directly owns 56,374 shares of the company’s stock, valued at approximately $4,712,302.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Mark Andrew Sherman sold 15,000 shares of the firm’s stock in a transaction dated Monday, May 8th. The stock was sold at an average price of $83.59, for a total transaction of $1,253,850.00. Following the completion of the transaction, the executive vice president now directly owns 56,374 shares in the company, valued at approximately $4,712,302.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Anjali Sud sold 8,873 shares of Dolby Laboratories stock in a transaction dated Friday, February 24th. The shares were sold at an average price of $82.00, for a total value of $727,586.00. Following the completion of the transaction, the director now owns 6,079 shares of the company’s stock, valued at approximately $498,478. The disclosure for this sale can be found here. In the last ninety days, insiders sold 64,960 shares of company stock valued at $5,443,790. 39.25% of the stock is owned by insiders.

Hedge Funds Weigh In On Dolby Laboratories

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Altshuler Shaham Ltd acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth about $31,000. Belpointe Asset Management LLC acquired a new position in Dolby Laboratories during the fourth quarter worth approximately $26,000. Tower Research Capital LLC TRC increased its holdings in shares of Dolby Laboratories by 52.7% in the first quarter. Tower Research Capital LLC TRC now owns 400 shares of the electronics maker’s stock valued at $34,000 after purchasing an additional 138 shares during the period. Harvest Fund Management Co. Ltd acquired a new position in shares of Dolby Laboratories in the first quarter valued at approximately $37,000. Finally, Ronald Blue Trust Inc. increased its holdings in shares of Dolby Laboratories by 40.9% in the fourth quarter. Ronald Blue Trust Inc. now owns 527 shares of the electronics maker’s stock valued at $35,000 after purchasing an additional 153 shares during the period. Hedge funds and other institutional investors own 82.30% of the company’s stock.

Dolby Laboratories Company Profile

(Get Rating)

Dolby Laboratories, Inc engages in the provision of audio and imaging technologies. It transforms entertainment and communications for content playback in movies, television, music, and gaming. Its products include Cinema Imaging Products, Cinema Audio Products, and other products such as 3-D kits, broadcast hardware and software, monitors, and solutions for hearing impaired consumers.